These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Meeting report from the Third Global Workshop on Melanoma. Agarwala SS; di Pietro A; Flaherty KT; Garbe C; Grob JJ; Kashani-Sabet M; Kirkwood JM; Leachman S; Messina J; O'Day S; Ribas A; Sondak V Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-7. PubMed ID: 20718940 [No Abstract] [Full Text] [Related]
9. Melanoma. Benson C; Gore ME Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036 [No Abstract] [Full Text] [Related]
10. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma. Fraker DL; Alexander HR Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489 [No Abstract] [Full Text] [Related]
11. [Therapy of cutaneous melanoma]. Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818 [TBL] [Abstract][Full Text] [Related]
12. Melanoma--new developments in diagnosis and therapy. Schneeberger A; Wagner SN Cancer Chemother Biol Response Modif; 2003; 21():609-36. PubMed ID: 15338766 [No Abstract] [Full Text] [Related]
13. Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma. Bajetta E Nat Clin Pract Oncol; 2008 Jan; 5(1):4-5. PubMed ID: 18043604 [No Abstract] [Full Text] [Related]
14. Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laser. Zeitouni NC; Dawson K; Cheney RT Br J Dermatol; 2005 Feb; 152(2):376-7. PubMed ID: 15727662 [No Abstract] [Full Text] [Related]